How can we use biologics and surgery to get the best outcomes for patients with CRSwNP?

The management of patients with Chronic Rhinosinusitis with Nasal Polyps (or CRSwNP) has been subject to a major revolution of care, considering the improved knowledge of the underlying pathology over the past two decades, the recommendation to evaluate biomarkers with the indication of biologics, and the increased awareness of comorbidities.

For several years, biologics have been indicated and available in a growing number of countries for severe uncontrolled CRSwNP. However, surgery (or even revision surgery) remains the most widely used option in most countries around the world.

This debate aims to explore the main therapeutic options and to address the main question: How can we use biologics and surgery to achieve the best outcomes for patients with CRSwNP?

Panellists:

Prof. Wytske Fokkens
Prof. Adam Chaker
Prof. Joseph Han
Prof. Joaquim Mullol
Ms. Daisy Waeyenbergh
Ms. Natascha Siemes

This Innovation Forum was supported by an unrestricted educational grant from GSK

----------------------------------------------------------------------------------------------------------------------

📖 Download EUFOREA's Chronic Rhinosinusitis Pocket Guide in English and en Español here:

👉 Chronic Rhinosinusitis Algorithm

📝 Read the Letter to the Editor published in Rhinology Journal here:
-----------------------------------------------------------------------------------------------------------------------
📽 Subscribe to our YouTube Channel for our latest videos on Allergies and Airway Diseases
--------------------------------------------------------------------------------------------------------------------------
📧 Get in touch with the EUFOREA team for any questions
--------------------------------------------------------------------------------------------------------------------------
📌 EUFOREA is an international non-profit organisation aiming to implement optimal patient care for allergies and airway diseases (asthma, chronic rhinosinusitis, rhinitis) and comorbidities through education, research and advocacy. #euforea

📍Follow us on social media